FIELD: pharmaceuticals; medicine.
SUBSTANCE: invention relates to compounds of formula (I)
(I).
EFFECT: new compounds having inhibitory activity against O-GlcNAc, as well as pharmaceutical compositions based on them and methods for the treatment of mediated diseases are obtained.
22 cl, 2 tbl, 40 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SELECTIVE GLYCOSIDASE INHIBITORS AND THEIR APPLICATION | 2012 |
|
RU2625308C2 |
| SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2592285C2 |
| PERMEABLE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2013 |
|
RU2707292C2 |
| SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2609210C2 |
| MACROCYCLIZATION REACTIONS AND INTERMEDIATE COMPOUNDS AND OTHER FRAGMENTS SUITABLE FOR PREPARING ANALOGUES OF HALICHONDRIN B | 2014 |
|
RU2710545C2 |
| SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
| AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
| RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
| PRINCE REACTION AND INTERMEDIATE PRODUCTS USED IN SYNTHESIS OF HALICHONDRIN MACROLIDES AND THEIR ANALOGUES | 2017 |
|
RU2777913C2 |
| DERIVATIVES OF PYRROLOPYRIMIDINE USEFUL AS JAK-KINASES INHIBITORS | 2012 |
|
RU2618673C2 |
Authors
Dates
2018-11-20—Published
2013-10-30—Filed